Prevalence and prognostic value of gastroenterological manifestations of COVID-19 : data from the Russian University Clinic
AIM: Assessment of the prevalence and prognostic value of gastroenterological manifestations in patients with COVID-19.
MATERIALS AND METHODS: A single-center retrospective cohort study was carried out. Only cases with laboratory confirmed detection of SARS-CoV-2 virus RNA using polymerase chain reaction in oro-/nasopharyngeal smear samples were subject to analysis. Patients with documented (according to anamnestic data and/or according to examination data during hospitalization) organic pathology of the gastrointestinal tract (GIT) and/or hepatobiliary system, malignant neoplasms of any localization, as well as pregnant patients were excluded from the general register of retrospective data. The final cohort was divided into two groups depending on the presence of gastrointestinal symptoms: COVID-19 with gastrointestinal symptoms (cases) and COVID-19 without gastrointestinal symptoms (control).
RESULTS: The final sample consisted of 3764 patients, including 2108 (56%) women and 1656 (44%) men. The average age of the subjects included in the analysis was 58.0 years (95% confidence interval CI 48.663.0). In the study cohort, gastroenterological manifestations (alone or in combination) were recorded in 885 (23.51%) patients. Calculation of the odds ratio (OR) of unfavorable and lethal outcomes between the analyzed groups showed that the presence of gastroenterological symptoms significantly increases the chances of lethal outcome in a cohort of elderly and senile patients (OR 1.6817, 95% CI 1.03352.7364; p=0.0364), determines a higher risk of hospitalization or transfer to the intensive care unit (OR 1.2959, 95% CI 1.05471.5922; p=0.0136), development of acute respiratory distress syndrome (OR 1.5952, 95% CI 1.31641.9329; p0.0001), as well as the need for mechanical ventilation (OR 1.2849, 95% CI 1.0771.5329; p=0.0054).
CONCLUSION: The present study has demonstrated that gastroenterological symptoms are detected in about one in four patients infected with the SARS-CoV-2 virus and multiply the risk of adverse and life-threatening complications of COVID-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:93 |
|---|---|
| Enthalten in: |
Terapevticheskii arkhiv - 93(2021), 8 vom: 15. Aug., Seite 853-861 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
Ianushevich, O O [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
63231-63-0 |
|---|
| Anmerkungen: |
Date Completed 28.10.2022 Date Revised 28.10.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.26442/00403660.2021.08.200977 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM348013841 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM348013841 | ||
| 003 | DE-627 | ||
| 005 | 20231226035204.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2021 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.26442/00403660.2021.08.200977 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1159.xml |
| 035 | |a (DE-627)NLM348013841 | ||
| 035 | |a (NLM)36286878 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Ianushevich, O O |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prevalence and prognostic value of gastroenterological manifestations of COVID-19 |b data from the Russian University Clinic |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.10.2022 | ||
| 500 | |a Date Revised 28.10.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a AIM: Assessment of the prevalence and prognostic value of gastroenterological manifestations in patients with COVID-19 | ||
| 520 | |a MATERIALS AND METHODS: A single-center retrospective cohort study was carried out. Only cases with laboratory confirmed detection of SARS-CoV-2 virus RNA using polymerase chain reaction in oro-/nasopharyngeal smear samples were subject to analysis. Patients with documented (according to anamnestic data and/or according to examination data during hospitalization) organic pathology of the gastrointestinal tract (GIT) and/or hepatobiliary system, malignant neoplasms of any localization, as well as pregnant patients were excluded from the general register of retrospective data. The final cohort was divided into two groups depending on the presence of gastrointestinal symptoms: COVID-19 with gastrointestinal symptoms (cases) and COVID-19 without gastrointestinal symptoms (control) | ||
| 520 | |a RESULTS: The final sample consisted of 3764 patients, including 2108 (56%) women and 1656 (44%) men. The average age of the subjects included in the analysis was 58.0 years (95% confidence interval CI 48.663.0). In the study cohort, gastroenterological manifestations (alone or in combination) were recorded in 885 (23.51%) patients. Calculation of the odds ratio (OR) of unfavorable and lethal outcomes between the analyzed groups showed that the presence of gastroenterological symptoms significantly increases the chances of lethal outcome in a cohort of elderly and senile patients (OR 1.6817, 95% CI 1.03352.7364; p=0.0364), determines a higher risk of hospitalization or transfer to the intensive care unit (OR 1.2959, 95% CI 1.05471.5922; p=0.0136), development of acute respiratory distress syndrome (OR 1.5952, 95% CI 1.31641.9329; p0.0001), as well as the need for mechanical ventilation (OR 1.2849, 95% CI 1.0771.5329; p=0.0054) | ||
| 520 | |a CONCLUSION: The present study has demonstrated that gastroenterological symptoms are detected in about one in four patients infected with the SARS-CoV-2 virus and multiply the risk of adverse and life-threatening complications of COVID-19 | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a abdominal pain | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a diarrhea | |
| 650 | 4 | |a gastrointestinal tract | |
| 650 | 4 | |a nausea | |
| 650 | 4 | |a vomiting | |
| 650 | 7 | |a RNA |2 NLM | |
| 650 | 7 | |a 63231-63-0 |2 NLM | |
| 700 | 1 | |a Maev, I V |e verfasserin |4 aut | |
| 700 | 1 | |a Krikheli, N I |e verfasserin |4 aut | |
| 700 | 1 | |a Levchenko, O V |e verfasserin |4 aut | |
| 700 | 1 | |a Rogova, I V |e verfasserin |4 aut | |
| 700 | 1 | |a Zaborovskii, A V |e verfasserin |4 aut | |
| 700 | 1 | |a Andreev, D N |e verfasserin |4 aut | |
| 700 | 1 | |a Kebina, A L |e verfasserin |4 aut | |
| 700 | 1 | |a Bordin, D S |e verfasserin |4 aut | |
| 700 | 1 | |a Bakulin, I G |e verfasserin |4 aut | |
| 700 | 1 | |a Bakulina, N V |e verfasserin |4 aut | |
| 700 | 1 | |a Andreev, N G |e verfasserin |4 aut | |
| 700 | 1 | |a Asadulin, P O |e verfasserin |4 aut | |
| 700 | 1 | |a Bagdasarian, A S |e verfasserin |4 aut | |
| 700 | 1 | |a Devkota, M K |e verfasserin |4 aut | |
| 700 | 1 | |a Evarnitskaia, N R |e verfasserin |4 aut | |
| 700 | 1 | |a Krikunova, O V |e verfasserin |4 aut | |
| 700 | 1 | |a Kucher, S A |e verfasserin |4 aut | |
| 700 | 1 | |a Sokolov, F S |e verfasserin |4 aut | |
| 700 | 1 | |a Fomenko, A K |e verfasserin |4 aut | |
| 700 | 1 | |a Khar'kovskii, V A |e verfasserin |4 aut | |
| 700 | 1 | |a Sharina, I A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Terapevticheskii arkhiv |d 1949 |g 93(2021), 8 vom: 15. Aug., Seite 853-861 |w (DE-627)NLM000055425 |x 0040-3660 |7 nnns |
| 773 | 1 | 8 | |g volume:93 |g year:2021 |g number:8 |g day:15 |g month:08 |g pages:853-861 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.26442/00403660.2021.08.200977 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 93 |j 2021 |e 8 |b 15 |c 08 |h 853-861 | ||